Health · Public Health & Disease · 8 hrs ago
WHO says one in six common bacterial infections resisted antibiotics in 2023
One in six common bacterial infections tested in 2023 resisted antibiotics, the World Health Organization says.
This growing problem, known as antimicrobial resistance, occurs when microbes no longer respond to medicines designed to treat them.
It affects people and animals, and can also disrupt food production and add costs for health systems.
In 2021, resistant bacterial infections were associated with more than 4.7 million deaths worldwide, including 1.14 million deaths directly attributed to resistance.
Misusing antimicrobials can help resistance spread, including taking antibiotics for viral illnesses or stopping treatment early without medical advice.
Vaccination, handwashing, timely diagnosis and following professional instructions can help reduce infections and the need for these medicines.
The WHO approved a global plan for 2026–2036 focused on preventing infections, improving monitoring and promoting responsible medicine use.
The WHO says one in six laboratory-confirmed common bacterial infections in 2023 was resistant to antibiotics.
Antimicrobial resistance can make infections harder to treat and put pressure on health systems.
The WHO estimates treatment of resistant bacterial infections could cost USD 412 billion annually through 2035.
The article says the global cost, including lost productivity, could reach USD 855 billion a year by 2035.
The WHO’s response includes a 2026–2036 global plan based on the One Health approach.
- Who
- The World Health Organization (WHO).
- What
- It reported that one in six laboratory-confirmed common bacterial infections in 2023 was resistant to antibiotics.
- When
- The finding concerns infections confirmed in 2023. The article was published on November 21, 2026.
- Where
- Global; the article does not identify a specific location for the finding.
- Why
- Antimicrobial resistance can make infections harder to treat and increase health-care costs.
This story does not have two clearly opposing sides.
Resistance increased in more than 40% of the pathogen-and-antibiotic combinations under international monitoring.
More than 4.7 million deaths were associated with resistant bacterial infections, including 1.14 million directly attributed to them.
One in six laboratory-confirmed common bacterial infections was resistant to antibiotics.
The WHO approved a global plan for 2026–2036.
- Resistant infections in 2023
- One in six laboratory-confirmed common bacterial infections
- Resistance trend, 2018–2023
- Increased in more than 40% of monitored pathogen-and-antibiotic combinations
- Deaths in 2021
- More than 4.7 million associated with resistant bacterial infections; 1.14 million directly attributed
- Treatment costs through 2035
- USD 412 billion annually, estimated by the WHO
- Global cost by 2035
- USD 855 billion annually, including lost productivity
- WHO global plan
- 2026–2036
What people are saying
One health, one action: prevent antimicrobial resistance now